Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Gerfaud-Valentin

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Rheumatology (Oxford, England)|December 17, 2021
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patientsMickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, et al.
Rheumatology (Oxford, England)|October 18, 2017
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasomeYvan Jamilloux, Lucie Lefeuvre, Flora Magnotti, et al.
Autoimmunity Reviews|July 8, 2021
Cardiovascular outcome in adult-onset Kawasaki diseaseElise Peter, Jean-Baptiste Fraison, Brahim Harbaoui, et al.
Blood|June 30, 2016
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopeniaMatthieu Mahévas, Mathieu Gerfaud-Valentin, Guillaume Moulis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 16, 2023
AQP5, a second gene at play with CFTR in aquagenic palmoplantar keratodermaBrian Sperelakis-Beedham, Maureen Lopez, Emmanuelle Bourrat, et al.
British Journal of Haematology|May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experienceEtienne Crickx, Mikael Ebbo, Etienne Rivière, et al.
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
Annals of the Rheumatic Diseases|November 20, 2024
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitisSophie Nagle, Yann Nguyen, Mary-Jane Guerry, et al.
RMD Open|July 22, 2022
Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patientsMohamed-Yacine Khitri, Alexis F Guedon, Sophie Georgin-Lavialle, et al.
The Journal of Experimental Medicine|February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophagesOmmar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Rheumatology (Oxford, England)|December 17, 2021
Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patientsMickaël Roussotte, Mathieu Gerfaud-Valentin, Arnaud Hot, et al.
Rheumatology (Oxford, England)|October 18, 2017
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasomeYvan Jamilloux, Lucie Lefeuvre, Flora Magnotti, et al.
Autoimmunity Reviews|July 8, 2021
Cardiovascular outcome in adult-onset Kawasaki diseaseElise Peter, Jean-Baptiste Fraison, Brahim Harbaoui, et al.
Blood|June 30, 2016
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopeniaMatthieu Mahévas, Mathieu Gerfaud-Valentin, Guillaume Moulis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 16, 2023
AQP5, a second gene at play with CFTR in aquagenic palmoplantar keratodermaBrian Sperelakis-Beedham, Maureen Lopez, Emmanuelle Bourrat, et al.
British Journal of Haematology|May 29, 2023
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experienceEtienne Crickx, Mikael Ebbo, Etienne Rivière, et al.
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
Annals of the Rheumatic Diseases|November 20, 2024
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitisSophie Nagle, Yann Nguyen, Mary-Jane Guerry, et al.
RMD Open|July 22, 2022
Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patientsMohamed-Yacine Khitri, Alexis F Guedon, Sophie Georgin-Lavialle, et al.
The Journal of Experimental Medicine|February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophagesOmmar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Pageof 9